Literature DB >> 15510844

Combined large cell neuroendocrine carcinoma.

Toshiya Bessho1, Keiya Yokochi, Teruhisa Sakurai.   

Abstract

We report a case of combined large cell neuroendocrine carcinoma. A 78-year-old man with vertigo was referred to our hospital where chest X-ray revealed a tumor shadow in the right lung. A transbronchial lung biopsy specimen verified a diagnosis of non-small cell lung carcinoma (cT1N0M0). Right lower lobectomy with mediastinal lymph node dissection (#7, 8, 9) was performed. A postoperative histological diagnosis was combined large cell neuroendocrine carcinoma of a component of squamous cell carcinoma [pT4 (pm) N2M0]. The patient received concurrent chemoradiotherapy due to upper mediastinal lymph node metastasis 4 months after surgery. The chemoradiotherapy well responded and the patient remains well 9 months after surgery.

Entities:  

Mesh：

Year:  2004        PMID： 15510844     DOI： 10.1007/s11748-004-0037-8

Source DB:  PubMed          Journal:  Jpn J Thorac Cardiovasc Surg        ISSN： 1344-4964


  9 in total

1.  Lung tumors with mixed histologic pattern. Clinico-pathologic characteristics and prognostic significance.

Authors:  Enrico Ruffini; Ottavio Rena; Alberto Oliaro; Pier Luigi Filosso; Massimo Bongiovanni; Anna Arslanian; Esther Papalia; Giuliano Maggi
Journal:  Eur J Cardiothorac Surg       Date:  2002-11       Impact factor: 4.191

2.  Large cell neuroendocrine carcinoma of the lung: a histologic and immunohistochemical study of 22 cases.

Authors:  S X Jiang; T Kameya; M Shoji; Y Dobashi; J Shinada; H Yoshimura
Journal:  Am J Surg Pathol       Date:  1998-05       Impact factor: 6.394

3.  Prognostic factors in neuroendocrine lung tumors: a Spanish Multicenter Study. Spanish Multicenter Study of Neuroendocrine Tumors of the Lung of the Spanish Society of Pneumonology and Thoracic Surgery (EMETNE-SEPAR).

Authors:  M García-Yuste; J M Matilla; T Alvarez-Gago; J L Duque; F Heras; L J Cerezal; G Ramos
Journal:  Ann Thorac Surg       Date:  2000-07       Impact factor: 4.330

4.  Neuroendocrine tumors of the lung with proposed criteria for large-cell neuroendocrine carcinoma. An ultrastructural, immunohistochemical, and flow cytometric study of 35 cases.

Authors:  W D Travis; R I Linnoila; M G Tsokos; C L Hitchcock; G B Cutler; L Nieman; G Chrousos; H Pass; J Doppman
Journal:  Am J Surg Pathol       Date:  1991-06       Impact factor: 6.394

5.  Large cell neuroendocrine carcinoma and large cell carcinomas with neuroendocrine morphology of the lung: prognosis after complete resection and systematic nodal dissection.

Authors:  Joseph Zacharias; Andrew G Nicholson; George P Ladas; Peter Goldstraw
Journal:  Ann Thorac Surg       Date:  2003-02       Impact factor: 4.330

6.  Large cell neuroendocrine carcinoma of the lung: pathological study and clinical outcome of 18 resected cases.

Authors:  Julien Mazières; Ghislaine Daste; Laurent Molinier; Jean Berjaud; Marcel Dahan; Martine Delsol; Pierre Carles; Alain Didier; Jean-Marc Bachaud
Journal:  Lung Cancer       Date:  2002-09       Impact factor: 5.705

7.  Large cell neuroendocrine carcinoma of the lung: a clinicopathologic study of eighty-seven cases.

Authors:  Hidefumi Takei; Hisao Asamura; Arafumi Maeshima; Kenji Suzuki; Haruhiko Kondo; Toshiro Niki; Tesshi Yamada; Ryosuke Tsuchiya; Yoshihiro Matsuno
Journal:  J Thorac Cardiovasc Surg       Date:  2002-08       Impact factor: 5.209

8.  Immunohistochemical study of the expression of drug-resistant proteins in large cell neuroendocrine carcinoma of the lung.

Authors:  Daisuke Okada; Masashi Kawamoto; Kiyoshi Koizumi; Shigeo Tanaka; Yuh Fukuda
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2003-07

9.  Dose-escalation study of weekly irinotecan and daily carboplatin with concurrent thoracic radiotherapy for unresectable stage III non-small cell lung cancer.

Authors:  M Yamada; S Kudoh; H Fukuda; K Nakagawa; N Yamamoto; Y Nishimura; S Negoro; K Takeda; M Tanaka; M Fukuoka
Journal:  Br J Cancer       Date:  2002-07-29       Impact factor: 7.640
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.